The hidden cost driver your pharmacy strategy is missing: Taking control of specialty infusion spend

Please feel free to save or share this link to refer back to this offering. For in depth information or for scheduling, please visit the activity site directly as detailed in the activity description.
28 Jul

The hidden cost driver your pharmacy strategy is missing: Taking control of specialty infusion spend

The hidden cost driver your pharmacy strategy is missing: Taking control of specialty infusion spend

Tuesday, July 28, 2026 (12:00 AM to 11:59 PM)
1.0 PDCs
Provider: Arizent
Course Name: The hidden cost driver your pharmacy strategy is missing: Taking control of specialty infusion spend

Speaker: Raymond Brown, M.S., Pharm.D. Partner, North American Clinical Pharmacy Leader Mercer (Speaker)
Program Type: Seminar/Workshop
Registration URL: https://www.benefitnews.com/web-seminars/the-hidden-cost-driver-your-pharmacy-strategy-is-missing-taking-control-of-specialty-infusion-spend
The hidden cost driver your pharmacy strategy is missing: Taking control of specialty infusion spend, New York, New York
Email Details

You will leave with: A clear breakdown of how drugs end up on the medical vs. pharmacy benefit, and why that placement matters more than most plans realize The specific reasons medical specialty spend is harder to control: limited PBM tools, pricing variability, and dramatic cost swings by site of care How manufacturers build their commercialization strategy for infusion to be competitive for the provider & in the market The most common visibility, contracting, and utilization management gaps Mercer sees across self-funded employers Practical, near-term actions to regain control: line-level reporting, contracting levers, site-of-care steering, and integrated case management A real-world look at how dedicated infusion care coordination changes outcomes and cost from the member's first call forward

You're Registered!
Specialty drugs administered in clinical settings, are quietly becoming one of the largest, least-controlled cost drivers in self-funded health plans. Unlike pharmacy benefit spend, medical specialty drugs often sit outside traditional PBM formularies and rebate channels, leaving plan sponsors with limited visibility and even less negotiating leverage. Join Mercer and Leap for a candid, educational session on what's actually driving medical specialty spend, where the visibility and contracting gaps are hiding in your plan today, and the practical levers, from site-of-care steering to specialty pharmacy partnerships, that benefits leaders can use to take back control. This is not a product pitch. It's a working session for HR benefits Leaders, CFOs, and Consultants who want a clearer picture of where plan dollars are going before the next renewal conversation. You will leave with: A clear breakdown of how drugs end up on the medical vs. pharmacy benefit, and why that placement matters more than most plans realize The specific reasons medical specialty spend is harder to control: limited PBM tools, pricing variability, and dramatic cost swings by site of care How manufacturers build their commercialization strategy for infusion to be competitive for the provider & in the market The most common visibility, contracting, and utilization management gaps Mercer sees across self-funded employers Practical, near-term actions to regain control: line-level reporting, contracting levers, site-of-care steering, and integrated case management A real-world look at how dedicated infusion care coordination changes outcomes and cost from the member's first call forward

The hidden cost driver your pharmacy strategy is missing: Taking control of specialty infusion spend
The hidden cost driver your pharmacy strategy is missing: Taking control of specialty infusion spend
360 Madison Ave
New York, NY 10017-7111

Map & Directions